Cleared Special

K203321 - Cystoject Syringe Lever (FDA 510(k) Clearance)

Dec 2020
Decision
27d
Days
Class 2
Risk

K203321 is an FDA 510(k) clearance for the Cystoject Syringe Lever. This device is classified as a Piston Syringe Lever (Class II - Special Controls, product code QBL).

Submitted by Urogen Pharma, Ltd. (Ra'Anana, IL). The FDA issued a Cleared decision on December 9, 2020, 27 days after receiving the submission on November 12, 2020.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 880.5860. Controlled Compression Of A Piston Syringe.

Submission Details

510(k) Number K203321 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 12, 2020
Decision Date December 09, 2020
Days to Decision 27 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code QBL - Piston Syringe Lever
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5860
Definition Controlled Compression Of A Piston Syringe